Skip to content

Wheat Bran Retention Enema as Adjuvant Therapy in children with Lower Respiratory Tract Infection

Wheat Bran Retention Enema as Adjuvant Therapy in children with Lower Respiratory Tract Infection - Wheat bran enema in infants with Lower respiratory tract infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047319
Enrollment
40
Registered
2022-04-01
Start date
2022-04-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower respiratory tract infection

Interventions

The first group includes 18 patients who will receive conventional treatment and wheat bran enema. The second group includes 21 patients who will receive conventional treatment only.

Sponsors

Assiut university Asyut Egypt
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients>1 month and up to 6 years diagnosed with lower respiratory tract infection admitted to Children Hospital, Faculty of Medicine, Assiut University during the study period

Exclusion criteria

Exclusion criteria: Patients age less than one month and more than six years

Design outcomes

Primary

MeasureTime frame
In this work, we aimed to assess microparticle profiles, inflammatory and anti-inflammatory cytokine profiles in pediatric patients with CAP. Also, we aimed to assess the effect of the use of wheat bran retention enema on microparticle profile and inflammatory and anti-inflammatory cytokine profile in CAP to investigate the role of wheat bran as adjuvant therapy in the management of pediatric patients with CAP.

Secondary

MeasureTime frame
To the best of our knowledge, there is no current research addressing the role of wheat bran enema as adjuvant therapy in pediatric patients with CAP. In order to investigate the effect of wheat bran enema, we analyzed clinical, imaging and laboratory data regarding inflammatory and anti-inflammatory cytokine profiles in patients with CAP.

Countries

Africa

Contacts

Public ContactKhaled Saad

Assiut University Pediatric department

khaled.ali@med.au.edu.eg+20882368373

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026